MetrionAIIntelligence

Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading stock research

Loading market dashboard

My Watchlist

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

Liminatus Pharma, Inc. Class A Common Stock

LIMN

HealthcareNASDAQUS

$0.1422

-$0.009 (-5.95%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

LIMN

1Y-0.009 (-5.95%)

Candles, volume, SMA 20, and SMA 50

O 0.1512H 0.1548L 0.1359C 0.1422Date Jun 5

LIMN

SMA 20 SMA 50 Vol 2.80MEEarnings dates

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$3.82M

Volume?2.75M

Avg Volume?10.09M

52w Range$0.132 - $33.66

Beta?0.70

Price Performance

-29.1%

$0.2005 to $0.1422

YTD

-76.7%

$0.61 to $0.1422

-99.4%

$24.22 to $0.1422

N/A

history unavailable

N/A

history unavailable

10Y

N/A

history unavailable

Company Details

CEO, industry, employees, IPO date, currency, and website.

ShowHide

CEOChris Kim

IndustryBiotechnology

Employees3

IPO Date2025-05-01

CurrencyUSD

Websiteliminatuspharma.com

Related stocks

Check out other names from the same Biotechnology industry as LIMN.

ATHE-

Alterity Therapeutics Limited

3.90USD

N/A

BTAI-

BioXcel Therapeutics, Inc.

1.11USD

N/A

DYAI-

Dyadic International, Inc.

Jasper Therapeutics, Inc.

0.49USD

N/A

MAIA-

MAIA Biotechnology, Inc.

SAB Biotherapeutics, Inc.

3.38USD

N/A